Latest Content

Combination Treatment May Improve Survival in Recurrent Brain Cancer Subtype

November 27th 2024, 2:00pm

By Darlene Dobkowski, MA

Article

Survival improved in patients with recurrent grade 3 IDH-mutant astrocytoma who were treated with eflornithine and lomustine.

Parenting and Cancer: How Much Do Kids Need to Know?

November 26th 2024, 10:00pm

By Alex Biese

Article

Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about their cancer journeys.

Itovebi Combo May Improve Survival in Metastatic Breast Cancer Subtype

November 26th 2024, 8:00pm

By Spencer Feldman

Article

An Itovebi regimen demonstrated significantly longer progression-free survival compared with placebo in some with metastatic breast cancer.

The Importance of Gratitude During Cancer, Not Only in November

November 26th 2024, 6:00pm

By Sue McCarthy

Article

Through cancer and life’s challenges, having and showing gratitude changed everything for me.

Loqtorzi Plus Chemo May Improve Survival in Small Cell Lung Cancer

November 26th 2024, 4:00pm

By Alex Biese

Article

For patients with extensive-stage small cell lung cancer, Loqtorzi was shown to improve progression-free survival and overall survival.

Focusing Research on T-Cell ALL to Further Treatment Options

November 26th 2024, 2:00pm

By Darlene Dobkowski, MA

Video

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

FDA Accepts New Drug Application for Nubeqa Combo for Prostate Cancer Subset

November 25th 2024, 10:00pm

By Darlene Dobkowski, MA

Article

The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Opdivo May Improve Outcomes in High-Risk Muscle-Invasive Bladder Cancer

November 25th 2024, 8:00pm

By Spencer Feldman

Article

Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk muscle-invasive urothelial cancer after radical resection.

A Survivor's Thanksgiving: Celebrating Life's Blessings Post-Cancer

November 25th 2024, 6:00pm

By Tamron Little

Article

Celebrating Thanksgivings after cancer has made me appreciate all aspects of life even more and to truly cherish times of laughter and memories.

Opdivo Combo Shows Better Survival Benefits in Advanced Hodgkin Lymphoma

November 25th 2024, 4:00pm

By Ashley Chan

Article

Patients with advanced Hodgkin lymphoma demonstrated significantly improved survival benefits with an Opdivo regimen versus an Adcetris regimen.

Understanding Treatment Sequences in Managing R/R CLL

November 25th 2024, 2:00pm

By Ashley Chan

Video

For patients with relapsed or refractory CLL, an expert explained that it’s important to understand the order of how treatments are given.

What it Means to be Patient First in Cancer Care

November 24th 2024, 7:00pm

By Javin Brita

Article

Cassidy Lockwood was nominated for the 2024 CURE Extraordinary Healer Award for her exceptional patient-first care, expert knowledge and compassionate support of patients with cancer.

A Journey Into the Unknown With My Daughter’s Aggressive Brain Cancer

November 23rd 2024, 7:00pm

By Mark Younce

Article

When my daughter was diagnosed with a rare form of brain cancer, I was unsure about clinical trials but eventually learned that it was a lifeline that would save her.

T-Cell Therapy With Lete-Cel Demonstrates Efficacy in Sarcoma Subtypes

November 23rd 2024, 3:00pm

By Darlene Dobkowski, MA

Article

Researchers observed responses in patients with synovial sarcoma or myxoid/round cell liposarcoma treated with lete-cel.

PSMA-Targeted Radiation Drug for Prostate Cancer Subset Meets Study Goal

November 22nd 2024, 10:00pm

By Ryan Scott

Article

Patients with PSMA-positive metastatic castration-resistant prostate cancer showed benefits after receiving PSMA-targeted treatment.